hydroxyindoleacetic acid has been researched along with Epilepsy in 57 studies
(5-hydroxyindol-3-yl)acetic acid : A member of the class of indole-3-acetic acids that is indole-3-acetic acid substituted by a hydroxy group at C-5.
Epilepsy: A disorder characterized by recurrent episodes of paroxysmal brain dysfunction due to a sudden, disorderly, and excessive neuronal discharge. Epilepsy classification systems are generally based upon: (1) clinical features of the seizure episodes (e.g., motor seizure), (2) etiology (e.g., post-traumatic), (3) anatomic site of seizure origin (e.g., frontal lobe seizure), (4) tendency to spread to other structures in the brain, and (5) temporal patterns (e.g., nocturnal epilepsy). (From Adams et al., Principles of Neurology, 6th ed, p313)
| Excerpt | Relevance | Reference |
|---|---|---|
| "5-18 yrs with intractable epilepsy and comedicated with carbamazepine or valproate." | 9.09 | Plasma and urinary serotonin and 5-HIAA in children treated with lamotrigine for intractable epilepsy. ( Jović, NJ; Majkić-Singh, N; Milovanović, DD; Mirković, D, 1999) |
| "This study was designed to demonstrate a role of serotonin in the anticonvulsant effect of fluoxetine, a serotonin reuptake inhibitor, in genetically epilepsy-prone rats." | 7.69 | Role of serotonin in the anticonvulsant effect of fluoxetine in genetically epilepsy-prone rats. ( Cheong, JH; Dailey, JW; Jobe, PC; Ko, KH; Yan, QS, 1994) |
| "In order to investigate the mechanism of action of anticonvulsant drugs, we examined the effects of carbamazepine (CBZ) and antiepilepsirine (AE) on convulsions and on brain biogenic amines in genetically epilepsy-prone rats (GEPR)." | 7.68 | Evidence that carbamazepine and antiepilepsirine may produce a component of their anticonvulsant effects by activating serotonergic neurons in genetically epilepsy-prone rats. ( Bettendorf, AF; Burger, RL; Dailey, JW; Jobe, PC; Mishra, PK; Yan, QS, 1992) |
| "Cerebrospinal fluid (CSF) concentrations of 5-hydroxyindoleacetic acid (5-HIAA), homovanillic acid (HVA) and probenecid were examined in 14 children with epilepsy (ages 6 months to 17 years) and 17 controls (ages 14 months to 16 years)." | 7.65 | Reduced cerebrospinal fluid 5-hydroxyindoleacetic acid and homovanillic acid in children with epilepsy. ( Bowers, MB; Cohen, DJ; Shaywitz, BA, 1975) |
| "5-18 yrs with intractable epilepsy and comedicated with carbamazepine or valproate." | 5.09 | Plasma and urinary serotonin and 5-HIAA in children treated with lamotrigine for intractable epilepsy. ( Jović, NJ; Majkić-Singh, N; Milovanović, DD; Mirković, D, 1999) |
| "This study was designed to demonstrate a role of serotonin in the anticonvulsant effect of fluoxetine, a serotonin reuptake inhibitor, in genetically epilepsy-prone rats." | 3.69 | Role of serotonin in the anticonvulsant effect of fluoxetine in genetically epilepsy-prone rats. ( Cheong, JH; Dailey, JW; Jobe, PC; Ko, KH; Yan, QS, 1994) |
| "In order to investigate the mechanism of action of anticonvulsant drugs, we examined the effects of carbamazepine (CBZ) and antiepilepsirine (AE) on convulsions and on brain biogenic amines in genetically epilepsy-prone rats (GEPR)." | 3.68 | Evidence that carbamazepine and antiepilepsirine may produce a component of their anticonvulsant effects by activating serotonergic neurons in genetically epilepsy-prone rats. ( Bettendorf, AF; Burger, RL; Dailey, JW; Jobe, PC; Mishra, PK; Yan, QS, 1992) |
| " Vigabatrin, 50 mg kg-1, was administered orally as add-on therapy to 11 patients with drug-resistant complex partial epilepsy as a single dose, then once every third day for 2 months, every other day for 2 months and daily for 1 month." | 3.67 | The effect of different vigabatrin treatment regimens on CSF biochemistry and seizure control in epileptic patients. ( Ben-Menachem, E; Dahlgren, L; Haegele, KD; Hardenberg, J; Huebert, N; Mumford, JP; Persson, LI; Schechter, PJ, 1989) |
| "Maturation of monoamine neuronal systems was studied by measuring cerebrospinal fluid metabolites of dopamine (homovanillic acid) and serotonin (5-hydroxyindoleacetic acid) in 38 children with epilepsy and other neurological disorders, to whom probenecid had previously been administered." | 3.66 | Ontogeny of dopamine and serotonin metabolites in the cerebrospinal fluid of children with neurological disorders. ( Bowers, MB; Cohen, DJ; Leckman, JF; Shaywitz, BA; Young, JG, 1980) |
| "To assess the possible role of amine neurotransmitters in human epilepsy, we measured metabolites of serotonin (5-hydroxyindoleacetic acid [5-HIAA]), dopamine (homovanillic acid [HVA]), and norepinephrine (3-methoxy-4-hydroxyphenylethylene glycol [MHPG]) in the lumbar cerebrospinal fluid (CSF) of patients with partial complex seizures and in neurologic controls." | 3.66 | Monoamine metabolites in the CSF of epileptic patients. ( Fang, TY; Gauthier, SG; Laxer, KD; Missala, K; Sourkes, TL; Young, SN, 1979) |
| "Cerebrospinal fluid (CSF) concentrations of 5-hydroxyindoleacetic acid (5-HIAA), homovanillic acid (HVA) and probenecid were examined in 14 children with epilepsy (ages 6 months to 17 years) and 17 controls (ages 14 months to 16 years)." | 3.65 | Reduced cerebrospinal fluid 5-hydroxyindoleacetic acid and homovanillic acid in children with epilepsy. ( Bowers, MB; Cohen, DJ; Shaywitz, BA, 1975) |
| "In 6 patients with intention myoclonus, the cerebrospinal fluid concentration of 5-hydroxyindoleacetic acid, a metabolite of serotonin was found to be significantly decreased." | 2.64 | Serotonin and myoclonus. ( Bowers, MB; Jutkowitz, R; Rosenbaum, D; Van Woert, MH, 1976) |
| "Six of them showed initial decrease of seizure frequency and severity and maintained improvement in some neurodevelopmental skills." | 1.72 | Monoamine neurotransmitters in early epileptic encephalopathies: New insights into pathophysiology and therapy. ( Aparicio, J; Artuch, R; Cortès-Saladelafont, E; Cuadras, D; Fons, C; García-Cazorla, À; Horvath, G; Juliá-Palacios, N; Molina-Anguita, C; Sigatulina Bondarenko, M, 2022) |
| "Loreclezole is an experimental anticonvulsant drug." | 1.29 | The anticonvulsant effect of the broad spectrum anticonvulsant loreclezole may be mediated in part by serotonin in rats: a microdialysis study. ( Dailey, JW; Jo, M; Jobe, PC; Ko, KH; Seo, DO; Yan, QS, 1994) |
| " El mouse convulsions were inhibited by chronic administration of citalopram (80 mg/kg/day, p." | 1.29 | Chronic administration of citalopram inhibited El mouse convulsions and decreased monoamine oxidase-A activity. ( Endo, A; Kabuto, H; Kurimoto, T; Mori, A; Takei, M; Yokoi, I, 1994) |
| "The 18 patients had either West syndrome (12 patients) or Lennox-Gastaut syndrome (6 patients), which was intractable to antiepileptic drug therapy and to adrenocorticotrophic hormone." | 1.29 | Thyrotropin-releasing hormone in treatment of intractable epilepsy: neurochemical analysis of CSF monoamine metabolites. ( Kawase, S; Matsuo, S; Mitsufuji, N; Nishimura, A; Sawada, T; Takeuchi, Y; Tominaga, M; Yamazoe, I, 1995) |
| "The Rett syndrome is a progressive disorder in female patients that is characterized by autistic behavior, dementia, ataxia, loss of purposeful use of the hands, and seizures." | 1.27 | Reduction of biogenic amine levels in the Rett syndrome. ( Butler, IJ; Glaze, DG; Percy, AK; Riccardi, VM; Zoghbi, HY, 1985) |
| "Transient hyperkinesia was observed in a 16-year-old epileptic and mentally retarded patient after a single intravenous perfusion of diphenylhydantoin (DPH)." | 1.26 | Transient hyperkinesia after a single intravenous perfusion of diphenylhydantoin. Report of a case associated with nontoxic plasma levels of diphenylhydantoin. ( Courjon, J; Dalery, J; de Villard, R; Mauguière, F, 1979) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 38 (66.67) | 18.7374 |
| 1990's | 14 (24.56) | 18.2507 |
| 2000's | 2 (3.51) | 29.6817 |
| 2010's | 2 (3.51) | 24.3611 |
| 2020's | 1 (1.75) | 2.80 |
| Authors | Studies |
|---|---|
| Juliá-Palacios, N | 1 |
| Molina-Anguita, C | 1 |
| Sigatulina Bondarenko, M | 1 |
| Cortès-Saladelafont, E | 1 |
| Aparicio, J | 1 |
| Cuadras, D | 1 |
| Horvath, G | 1 |
| Fons, C | 1 |
| Artuch, R | 1 |
| García-Cazorla, À | 2 |
| Horvath, GA | 1 |
| Demos, M | 1 |
| Shyr, C | 1 |
| Matthews, A | 1 |
| Zhang, L | 1 |
| Race, S | 1 |
| Stockler-Ipsiroglu, S | 1 |
| Van Allen, MI | 1 |
| Mancarci, O | 1 |
| Toker, L | 1 |
| Pavlidis, P | 1 |
| Ross, CJ | 1 |
| Wasserman, WW | 1 |
| Trump, N | 1 |
| Heales, S | 2 |
| Pope, S | 1 |
| Cross, JH | 1 |
| van Karnebeek, CD | 1 |
| Lin, WH | 1 |
| Huang, HP | 1 |
| Lin, MX | 1 |
| Chen, SG | 1 |
| Lv, XC | 1 |
| Che, CH | 1 |
| Lin, JL | 1 |
| Crawley, F | 1 |
| Rudge, P | 1 |
| Serrano, M | 1 |
| Pérez-Dueñas, B | 1 |
| González, V | 1 |
| Ormazábal, A | 1 |
| Pineda, M | 1 |
| Fernández-Alvarez, E | 1 |
| Campistol, JM | 1 |
| Artuch, RM | 1 |
| Bibileĭshvili, ShI | 1 |
| Avanesova, TS | 1 |
| Sviridova, EI | 1 |
| Young, SN | 5 |
| Gauthier, S | 3 |
| Anderson, GM | 2 |
| Purdy, WC | 1 |
| Shaywitz, BA | 4 |
| Cohen, DJ | 3 |
| Leckman, JF | 1 |
| Young, JG | 1 |
| Bowers, MB | 3 |
| Sellinger, OZ | 1 |
| Dietz, DD | 1 |
| Banki, CM | 1 |
| Molnár, G | 2 |
| Davis, BA | 1 |
| Mohan, A | 1 |
| Nag, D | 1 |
| Misra, RN | 1 |
| Gujrati, VR | 1 |
| Shanker, K | 1 |
| Doval, DC | 1 |
| Saxena, RC | 1 |
| Bhargava, KP | 1 |
| Joseph, MH | 1 |
| Baliga, L | 1 |
| Rao, A | 1 |
| Raja, A | 1 |
| Rao, SN | 1 |
| Verma, AK | 1 |
| Gupta, SK | 1 |
| Maheshwari, MC | 1 |
| Novotny, EJ | 1 |
| Ebersole, JS | 1 |
| Sullivan, CM | 1 |
| Gillespie, SM | 1 |
| Yan, QS | 4 |
| Jobe, PC | 4 |
| Cheong, JH | 1 |
| Ko, KH | 2 |
| Dailey, JW | 4 |
| Seo, DO | 1 |
| Jo, M | 1 |
| Kabuto, H | 2 |
| Yokoi, I | 2 |
| Endo, A | 1 |
| Takei, M | 1 |
| Kurimoto, T | 1 |
| Mori, A | 3 |
| Takeuchi, Y | 1 |
| Tominaga, M | 1 |
| Mitsufuji, N | 1 |
| Yamazoe, I | 1 |
| Kawase, S | 1 |
| Nishimura, A | 1 |
| Matsuo, S | 1 |
| Sawada, T | 1 |
| Kanthan, R | 1 |
| Shuaib, A | 1 |
| Griebel, R | 1 |
| el-Alazounni, H | 1 |
| Miyashita, H | 1 |
| Kalra, J | 1 |
| Jović, NJ | 1 |
| Mirković, D | 1 |
| Majkić-Singh, N | 1 |
| Milovanović, DD | 1 |
| Laxer, KD | 1 |
| Sourkes, TL | 2 |
| Fang, TY | 1 |
| Gauthier, SG | 1 |
| Missala, K | 1 |
| Chadwick, D | 4 |
| Jenner, P | 4 |
| Reynolds, EH | 4 |
| Green, AR | 1 |
| Grahame-Smith, DG | 1 |
| Nagao, T | 1 |
| Fujimoto, A | 1 |
| Ohshimo, T | 1 |
| Yamamoto, M | 1 |
| Kugoh, T | 1 |
| Akiyama, K | 1 |
| Otsuki, S | 1 |
| Carrieri, P | 1 |
| Orefice, G | 1 |
| Mandarini, A | 1 |
| Rossi, V | 1 |
| Campanella, G | 1 |
| Kobayashi, K | 1 |
| Mauguière, F | 1 |
| Dalery, J | 1 |
| de Villard, R | 1 |
| Courjon, J | 1 |
| Trimble, M | 1 |
| Driver, MV | 1 |
| Van Woert, MH | 1 |
| Jutkowitz, R | 1 |
| Rosenbaum, D | 1 |
| Koskiniemi, M | 1 |
| Livrea, P | 1 |
| Di Reda, L | 1 |
| Puca, FM | 1 |
| Genco, S | 1 |
| Specchio, L | 1 |
| Papagno, G | 1 |
| Makarov, AIu | 1 |
| Kiselev, VN | 1 |
| Loboda, EB | 1 |
| Chanarin, I | 1 |
| Mishra, PK | 1 |
| Burger, RL | 1 |
| Bettendorf, AF | 1 |
| Abed, WT | 1 |
| Shirakawa, J | 1 |
| Tanaka, C | 1 |
| Saijoh, K | 1 |
| Botez, MI | 1 |
| Bonuccelli, U | 1 |
| Garant, D | 1 |
| Fariello, R | 1 |
| Zoghbi, HY | 1 |
| Percy, AK | 1 |
| Glaze, DG | 1 |
| Butler, IJ | 1 |
| Riccardi, VM | 1 |
| Lloyd, KG | 1 |
| Scatton, B | 1 |
| Voltz, C | 1 |
| Bryere, P | 1 |
| Valin, A | 1 |
| Naquet, R | 1 |
| Carney, MW | 1 |
| Ben-Menachem, E | 1 |
| Persson, LI | 1 |
| Schechter, PJ | 1 |
| Haegele, KD | 1 |
| Huebert, N | 1 |
| Hardenberg, J | 1 |
| Dahlgren, L | 1 |
| Mumford, JP | 1 |
| Louw, D | 1 |
| Sutherland, GR | 1 |
| Glavin, GB | 1 |
| Girvin, J | 1 |
| Kimiya, S | 1 |
| Seki, T | 1 |
| Maezawa, M | 1 |
| Yamada, T | 1 |
| Tachibana, Y | 1 |
| Rohmer, F | 1 |
| Warter, JM | 1 |
| Coquillat, G | 1 |
| Maitrot, D | 1 |
| Kurtz, D | 1 |
| Micheletti, G | 1 |
| Mack, G | 1 |
| Mandel, P | 1 |
| Papeschi, R | 1 |
| Molina-Negro, P | 1 |
| Erba, G | 1 |
| Johnson, WT | 1 |
| Bowers, M | 1 |
| Fodor, A | 1 |
| Karczag, I | 1 |
| Szilágyi, A | 1 |
| Ujvárosi, I | 1 |
| Pakszys, W | 1 |
| Gromov, LA | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| [NCT00004325] | 200 participants | Observational | 1988-12-31 | Completed | |||
| The Effect of Vigabatrin on Cerebral Blood Flow and Glucose Metabolism[NCT00001489] | 20 participants | Observational | 1994-10-31 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
2 reviews available for hydroxyindoleacetic acid and Epilepsy
| Article | Year |
|---|---|
Brain monoamines in seizure mechanism (review).
Topics: Animals; Brain; Carbonic Anhydrase Inhibitors; Catecholamines; Child; Dextroamphetamine; Dopamine; E | 1977 |
Neuropharmacology of S-adenosyl methionine.
Topics: Animals; Antidepressive Agents; Biogenic Amines; Brain; Dementia; Depressive Disorder; Epilepsy; Fol | 1986 |
5 trials available for hydroxyindoleacetic acid and Epilepsy
| Article | Year |
|---|---|
Aspartame has no effect on seizures or epileptiform discharges in epileptic children.
Topics: Adolescent; Aspartame; Brain; Child; Child, Preschool; Dopamine; Double-Blind Method; Electroencepha | 1994 |
Plasma and urinary serotonin and 5-HIAA in children treated with lamotrigine for intractable epilepsy.
Topics: Adolescent; Anticonvulsants; Carbamazepine; Child; Child, Preschool; Drug Therapy, Combination; Epil | 1999 |
Manipulation of cerebral monoamines in the treatment of human epilepsy: a pilot study.
Topics: Adult; Biogenic Amines; Brain Chemistry; Carbamazepine; Drug Evaluation; Epilepsy; Homovanillic Acid | 1978 |
Serotonin and myoclonus.
Topics: 5-Hydroxytryptophan; Adolescent; Adult; Carbidopa; Clinical Trials as Topic; Epilepsy; Female; Homov | 1976 |
[Pharmacological and biochemical approach to a syndrome of action and intention myoclonus in the course of degenerative disease of the nervous system].
Topics: 5-Hydroxytryptophan; Adult; Benzazepines; Cerebellar Ataxia; Clinical Trials as Topic; Diagnosis, Di | 1973 |
50 other studies available for hydroxyindoleacetic acid and Epilepsy
| Article | Year |
|---|---|
Monoamine neurotransmitters in early epileptic encephalopathies: New insights into pathophysiology and therapy.
Topics: Child, Preschool; Electroencephalography; Epilepsies, Myoclonic; Epilepsy; Female; Humans; Hydroxyin | 2022 |
Secondary neurotransmitter deficiencies in epilepsy caused by voltage-gated sodium channelopathies: A potential treatment target?
Topics: Autistic Disorder; Channelopathies; Child; Drug Resistant Epilepsy; Epilepsy; Exome; Female; Homovan | 2016 |
Seizure-induced 5-HT release and chronic impairment of serotonergic function in rats.
Topics: Acute Disease; Animals; Brain; Chronic Disease; Electroencephalography; Epilepsy; Hippocampus; Hydro | 2013 |
Reversible parkinsonism following heroin pyrolysate inhalation is associated with tetrahydrobiopterin deficiency.
Topics: Adult; Biopterins; Brain; Brain Diseases, Metabolic; Electroencephalography; Epilepsy; Female; Heroi | 2004 |
Secondary abnormalities of neurotransmitters in infants with neurological disorders.
Topics: 5-Hydroxytryptophan; Atrophy; Brain; Electroencephalography; Epilepsy; Female; Homovanillic Acid; Hu | 2007 |
[Amino acid, tryptophan, as an antiepileptic agent].
Topics: Anticonvulsants; Drug Evaluation; Epilepsy; Epilepsy, Temporal Lobe; Humans; Hydroxyindoleacetic Aci | 1980 |
[Therapeutic activity of tryptophan and its effect on serotonin metabolism in epilepsy patients].
Topics: Epilepsy; Female; Humans; Hydroxyindoleacetic Acid; Male; Monoamine Oxidase; Serotonin; Time Factors | 1980 |
Tryptophan, 5-hydroxyindoleacetic acid and indoleacetic acid in human cerebrospinal fluid: interrelationships and the influence of age, sex, epilepsy and anticonvulsant drugs.
Topics: Adult; Age Factors; Anticonvulsants; Brain; Brain Chemistry; Epilepsy; Female; Humans; Hydroxyindole | 1980 |
Ontogeny of dopamine and serotonin metabolites in the cerebrospinal fluid of children with neurological disorders.
Topics: Adolescent; Child; Child, Preschool; Dopamine; Epilepsy; Female; Homovanillic Acid; Humans; Hydroxyi | 1980 |
The metabolism of 5-hydroxytryptamine in the methionine sulfoximine epileptogenic rat brain.
Topics: 5-Hydroxytryptophan; Animals; Brain; Epilepsy; Hydroxyindoleacetic Acid; Male; Methionine Sulfoximin | 1981 |
Cerebrospinal fluid 5-hydroxyindoleacetic acid as an index of central serotonergic processes.
Topics: Adult; Aged; Alcoholism; Brain; Depressive Disorder; Epilepsy; Female; Humans; Hydroxyindoleacetic A | 1981 |
Precursors and metabolites of phenylethylamine, m and p-tyramine and tryptamine in human lumbar and cisternal cerebrospinal fluid.
Topics: Adolescent; Adult; Anticonvulsants; Child; Child, Preschool; Epilepsy; Female; Humans; Hydroxyindole | 1982 |
Serotonergic and dopaminergic metabolites in cerebrospinal fluid of epileptics.
Topics: Adult; Dopamine; Epilepsy; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Serotonin | 1982 |
Studies on kynurenine in human cerebrospinal fluid: lowered levels in epilepsy.
Topics: Adolescent; Adult; Aged; Amino Acids; Anticonvulsants; Epilepsy; Epilepsy, Temporal Lobe; Humans; Hy | 1983 |
A study of urinary excretion of biogenic amine metabolites in epilepsy.
Topics: Adolescent; Adult; Biogenic Amines; Epilepsy; Female; Homovanillic Acid; Humans; Hydroxyindoleacetic | 1983 |
5-HIAA in cerebrospinal fluid of patients with status epilepticus.
Topics: Adolescent; Adult; Epilepsy; Female; Humans; Hydroxyindoleacetic Acid; Male; Middle Aged; Status Epi | 1984 |
Role of serotonin in the anticonvulsant effect of fluoxetine in genetically epilepsy-prone rats.
Topics: 5-Hydroxytryptophan; Animals; Anticonvulsants; Epilepsy; Female; Fenclonine; Fluoxetine; Hydroxyindo | 1994 |
The anticonvulsant effect of the broad spectrum anticonvulsant loreclezole may be mediated in part by serotonin in rats: a microdialysis study.
Topics: Acoustic Stimulation; Animals; Anticonvulsants; Dose-Response Relationship, Drug; Epilepsy; Genetic | 1994 |
Chronic administration of citalopram inhibited El mouse convulsions and decreased monoamine oxidase-A activity.
Topics: Administration, Oral; Animals; Anticonvulsants; Brain; Citalopram; Disease Models, Animal; Epilepsy; | 1994 |
Thyrotropin-releasing hormone in treatment of intractable epilepsy: neurochemical analysis of CSF monoamine metabolites.
Topics: Child; Child, Preschool; Electroencephalography; Epilepsy; Female; Homovanillic Acid; Humans; Hydrox | 1995 |
Further evidence of anticonvulsant role for 5-hydroxytryptamine in genetically epilepsy-prone rats.
Topics: 1-Naphthylamine; Acoustic Stimulation; Animals; Epilepsy; Extracellular Space; Hydroxyindoleacetic A | 1995 |
Evaluation of monoaminergic neurotransmitters in the acute focal ischemic human brain model by intracerebral in vivo microdialysis.
Topics: 3,4-Dihydroxyphenylacetic Acid; Analysis of Variance; Catecholamines; Chromatography, High Pressure | 1996 |
Monoamine metabolites in the CSF of epileptic patients.
Topics: Adolescent; Adult; Child; Epilepsy; Female; Glycols; Homovanillic Acid; Humans; Hydroxyindoleacetic | 1979 |
Amines, anticonvulsants, and epilepsy.
Topics: Adolescent; Adult; Anticonvulsants; Brain; Chromatography, Gas; Drug Therapy, Combination; Epilepsy; | 1975 |
Letter: Amines, anticonvulsants, and epilepsy.
Topics: Animals; Anticonvulsants; Dose-Response Relationship, Drug; Epilepsy; Humans; Hydroxyindoleacetic Ac | 1975 |
[Cerebrospinal fluid monoamine metabolites and cyclic nucleotides in the patients with epilepsy (author's transl)].
Topics: Adolescent; Adult; Aged; Cyclic AMP; Cyclic GMP; Epilepsy; Female; Glycols; Homovanillic Acid; Human | 1979 |
[Determination of HVA and 5-HIAA in epileptic syndromes in basal conditions and after treatment with probenecid].
Topics: Adolescent; Adult; Anticonvulsants; Brain; Dopamine; Epilepsy; Homovanillic Acid; Humans; Hydroxyind | 1979 |
Transient hyperkinesia after a single intravenous perfusion of diphenylhydantoin. Report of a case associated with nontoxic plasma levels of diphenylhydantoin.
Topics: Adolescent; Epilepsy; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Hyperkinesis; Infusions, | 1979 |
Reduced cerebrospinal fluid 5-hydroxyindoleacetic acid and homovanillic acid in children with epilepsy.
Topics: Acetazolamide; Adolescent; Age Factors; Child; Child, Preschool; Drug Therapy, Combination; Epilepsy | 1975 |
Findings in routine laboratory examination in progressive myoclonus epilepsy.
Topics: Adolescent; Adult; Age Factors; Blood Glucose; Blood Proteins; Cerebrospinal Fluid Proteins; Child; | 1975 |
Serotonin metabolism in human epilepsy: the influence of anticonvulsant drugs.
Topics: Adolescent; Adult; Anticonvulsants; Epilepsy; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; M | 1977 |
[Homovanillic acid (HVA) and 5-hydroxyindoleacetic acid (5-HIAA) levels in the lumbar cerebrospinal fluid in epileptic patients].
Topics: Adult; Epilepsy; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Phenylacetates; Spectrophotome | 1976 |
[The role of serotonin in the pathogenesis of epilepsy].
Topics: Adolescent; Adult; Arachnoiditis; Epilepsy; Female; Humans; Hydroxyindoleacetic Acid; Male; Seizures | 1975 |
Folate and monoamine metabolism in epilepsy.
Topics: Adolescent; Adult; Anticonvulsants; Biogenic Amines; Epilepsy; Erythrocytes; Folic Acid; Homovanilli | 1975 |
Evidence that carbamazepine and antiepilepsirine may produce a component of their anticonvulsant effects by activating serotonergic neurons in genetically epilepsy-prone rats.
Topics: Animals; Anticonvulsants; Brain; Carbamazepine; Chromatography, High Pressure Liquid; Epilepsy; Fema | 1992 |
Monoamine metabolites, iron induced seizures, and the anticonvulsant effect of tannins.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Anticonvulsants; Biogenic Monoamines; Brain; Catechin; Chlo | 1992 |
Anticonvulsant activity of di-n-propylacetate and brain monoamine metabolism in the rat.
Topics: Animals; Biogenic Monoamines; Brain; Catecholamines; Epilepsy; Female; gamma-Aminobutyric Acid; Homo | 1990 |
[5-Hydroxyindole acetic acid assay and the clinical significance].
Topics: Anorexia Nervosa; Chromatography, High Pressure Liquid; Chromatography, Ion Exchange; Depressive Dis | 1990 |
Effects of anticonvulsant treatment and low levels of folate and thiamine on amine metabolites in cerebrospinal fluid.
Topics: Adult; Biogenic Amines; Brain; Electroencephalography; Epilepsy; Female; Folic Acid; Homovanillic Ac | 1991 |
The acute convulsant effect of MPTP is dependent on intracerebral MPP+.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 3,4-Dihydroxyphenylacetic Acid; Animals; Brain Chemist | 1991 |
Reduction of biogenic amine levels in the Rett syndrome.
Topics: Adolescent; Ataxia; Autistic Disorder; Biogenic Amines; Child; Child, Preschool; Dementia; Electroen | 1985 |
Cerebrospinal fluid amino acid and monoamine metabolite levels of Papio papio: correlation with photosensitivity.
Topics: Amino Acids; Animals; Biogenic Amines; Epilepsy; Female; gamma-Aminobutyric Acid; Homovanillic Acid; | 1986 |
The effect of different vigabatrin treatment regimens on CSF biochemistry and seizure control in epileptic patients.
Topics: Adult; Aminocaproates; Anticonvulsants; Carnosine; Cerebrospinal Fluid Proteins; Epilepsy; Female; g | 1989 |
A study of monoamine metabolism in human epilepsy.
Topics: 3,4-Dihydroxyphenylacetic Acid; Adult; Epilepsy; Female; Hippocampus; Homovanillic Acid; Humans; Hyd | 1989 |
Analysis of monamine metabolism in cerebrospinal fluid in childhood epilepsies.
Topics: Adolescent; Brain Damage, Chronic; Child; Child, Preschool; Epilepsies, Myoclonic; Epilepsy; Epileps | 1989 |
The concentration of homovanillic and 5-hydroxyindoleacetic acids in ventricular and lumbar CSF. Studies in patients with extrapyramidal disorders, epilepsy, and other diseases.
Topics: Adolescent; Adult; Basal Ganglia Diseases; Cerebral Palsy; Cerebral Ventricles; Diazepam; Dihydroxyp | 1972 |
Biogenic amines in autistic and atypical children. Cerebrospinal fluid measures of homovanillic acid and 5-hydroxyindoleacetic acid.
Topics: Autistic Disorder; Brain; Child; Child, Preschool; Diagnosis, Differential; Dopamine; Electroencepha | 1974 |
5-Hydroxyindoleacetic acid in cerebrospinal fluid.
Topics: Adult; Age Factors; Brain Diseases; Brain Stem; Depression; Epilepsy; Humans; Hydroxyindoleacetic Ac | 1973 |
[Effect of 5,5-diphenylhydantoin and pneumoencephalography on urinary excretion of 5-hydroxyindoloacetic acid, a serotonin metabolite, and serum ceruloplasmin activity in epileptics].
Topics: Administration, Oral; Adolescent; Adult; Ceruloplasmin; Epilepsy; Female; Humans; Hydroxyindoleaceti | 1971 |
[The neuromediator mechanisms of a convulsive seizure].
Topics: Acetylcholine; Adolescent; Adult; Child; Cholinesterases; Epilepsy; Epinephrine; Humans; Hydroxyindo | 1971 |